These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2080 related articles for article (PubMed ID: 22497512)

  • 1. Ex-vivo expanded baboon CD4+ CD25 Hi Treg cells suppress baboon anti-pig T and B cell immune response.
    Singh AK; Seavey CN; Horvath KA; Mohiuddin MM
    Xenotransplantation; 2012; 19(2):102-11. PubMed ID: 22497512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and expansion of baboon CD4+CD25+ Treg cells for potential use in a non-human primate xenotransplantation model.
    Porter CM; Horvath-Arcidiacono JA; Singh AK; Horvath KA; Bloom ET; Mohiuddin MM
    Xenotransplantation; 2007 Jul; 14(4):298-308. PubMed ID: 17669171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin promotes the enrichment of CD4(+)CD25(hi)FoxP3(+) T regulatory cells from naïve CD4(+) T cells of baboon that suppress antiporcine xenogenic response in vitro.
    Singh AK; Horvath KA; Mohiuddin MM
    Transplant Proc; 2009; 41(1):418-21. PubMed ID: 19249569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foxp3 regulates human natural CD4+CD25+ regulatory T-cell-mediated suppression of xenogeneic response.
    Sun L; Yi S; O'Connell PJ
    Xenotransplantation; 2010; 17(2):121-30. PubMed ID: 20522244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting acute allograft rejection by immunotherapy with ex vivo-expanded natural CD4+ CD25+ regulatory T cells.
    Xia G; He J; Zhang Z; Leventhal JR
    Transplantation; 2006 Dec; 82(12):1749-55. PubMed ID: 17198271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro expanded human CD4+CD25+ regulatory T cells are potent suppressors of T-cell-mediated xenogeneic responses.
    Wu J; Yi S; Ouyang L; Jimenez E; Simond D; Wang W; Wang Y; Hawthorne WJ; O'Connell PJ
    Transplantation; 2008 Jun; 85(12):1841-8. PubMed ID: 18580479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced suppression of the xenogeneic T-cell response in vitro by xenoantigen stimulated and expanded regulatory T cells.
    Jin X; Wang Y; Hawthorne WJ; Hu M; Yi S; O'Connell P
    Transplantation; 2014 Jan; 97(1):30-8. PubMed ID: 24092378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.
    Qu Y; Zhang B; Zhao L; Liu G; Ma H; Rao E; Zeng C; Zhao Y
    Transpl Immunol; 2007 Apr; 17(3):153-61. PubMed ID: 17331841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+Foxp3+ regulatory T cells converted by rapamycin from peripheral CD4+CD25(-) naive T cells display more potent regulatory ability in vitro.
    Chen JF; Gao J; Zhang D; Wang ZH; Zhu JY
    Chin Med J (Engl); 2010 Apr; 123(7):942-8. PubMed ID: 20497692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis.
    Keever-Taylor CA; Browning MB; Johnson BD; Truitt RL; Bredeson CN; Behn B; Tsao A
    Cytotherapy; 2007; 9(2):144-57. PubMed ID: 17453966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro-expanded CD4(+)CD25(high)Foxp3(+) regulatory T cells controls corneal allograft rejection.
    Guo X; Jie Y; Ren D; Zeng H; Zhang Y; He Y; Pan Z
    Hum Immunol; 2012 Nov; 73(11):1061-7. PubMed ID: 22939904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.
    Bocian K; Borysowski J; Wierzbicki P; Wyzgal J; Klosowska D; Bialoszewska A; Paczek L; Górski A; Korczak-Kowalska G
    Nephrol Dial Transplant; 2010 Mar; 25(3):710-7. PubMed ID: 19903662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expansion of CD4(+)CD25 (+) regulatory T cells from cord blood CD4(+) cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin.
    Asanuma S; Tanaka J; Sugita J; Kosugi M; Shiratori S; Wakasa K; Shono Y; Shigematsu A; Kondo T; Kobayashi T; Asaka M; Imamura M
    Ann Hematol; 2011 Jun; 90(6):617-24. PubMed ID: 21107839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical-grade preparation of human natural regulatory T-cells encoding the thymidine kinase suicide gene as a safety gene.
    Guillot-Delost M; Cheraï M; Hamel Y; Rosenzwajg M; Baillou C; Simonin G; Leclercq V; Mariotti-Ferrandiz ME; Six A; Bon-Durand V; Maury S; Salomon BL; Cohen JL; Klatzmann D; Lemoine FM
    J Gene Med; 2008 Aug; 10(8):834-46. PubMed ID: 18615770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adoptive transfusion of ex vivo donor alloantigen-stimulated CD4(+)CD25(+) regulatory T cells ameliorates rejection of DA-to-Lewis rat liver transplantation.
    Pu LY; Wang XH; Zhang F; Li XC; Yao AH; Yu Y; Lv L; Li GQ
    Surgery; 2007 Jul; 142(1):67-73. PubMed ID: 17630002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody can prevent rat cardiac allograft rejection.
    Kitazawa Y; Fujino M; Sakai T; Azuma H; Kimura H; Isaka Y; Takahara S; Hünig T; Abe R; Li XK
    J Heart Lung Transplant; 2008 Apr; 27(4):362-71. PubMed ID: 18374871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
    Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
    Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo-expanded baboon CD39 +  regulatory T cells prevent rejection of porcine islet xenografts in NOD-SCID IL-2rγ
    Huang D; Wang Y; Hawthorne WJ; Hu M; Hawkes J; Burns H; Davies S; Gao F; Chew YV; Yi S; O'Connell PJ
    Xenotransplantation; 2017 Nov; 24(6):. PubMed ID: 28963731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bortezomib can suppress activation of rapamycin-resistant memory T cells without affecting regulatory T-cell viability in non-human primates.
    Kim JS; Lee JI; Shin JY; Kim SY; Shin JS; Lim JH; Cho HS; Yoon IH; Kim KH; Kim SJ; Park CG
    Transplantation; 2009 Dec; 88(12):1349-59. PubMed ID: 20029331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
    Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 104.